Principles, Classification, and Clinical Laboratory Applications of Hematologic Cytochemical Staining
Principles, Classification, and Clinical Laboratory Applications of Hematologic Cytochemical Staining
Hematologic cytochemical staining is a group of detection methods that, on the basis of cellular morphology, use specific chemical reactions to demonstrate intracellular enzymes, glycogen, lipids, iron granules, and other functional components. Its value is not to replace flow cytometric immunophenotyping, cytogenetics, or molecular testing, but to provide clues about cell lineage, differentiation stage, and functional status in the preliminary differentiation of bone marrow smears, peripheral blood smears, and hematologic diseases.
Keywords: hematologic cytochemical staining; bone marrow smear; peripheral blood smear; peroxidase staining; Sudan Black B staining; nonspecific esterase staining; specific esterase staining; PAS staining; neutrophil alkaline phosphatase; iron staining; leukemia differentiation
1 Basic Positioning of Hematologic Cytochemical Staining
1.1 Detection Targets
(1) Intracellular enzyme activity
Hematologic cytochemical staining can demonstrate the activity of certain enzymes in myeloid cells, monocytes, lymphocytes, megakaryocytes, and erythroid cells, such as myeloperoxidase, specific esterase, nonspecific esterase, alkaline phosphatase, and acid phosphatase. These enzyme activities are associated with cell lineage and differentiation stage.
(2) Intracellular chemical components
Some staining methods are used to demonstrate glycogen, lipids, iron granules, and reticular-fiber-related components. For example, PAS staining is used to observe glycogen and glycoproteins, while iron staining is used to evaluate bone marrow iron stores and ring sideroblasts.
(3) Cellular functional status
Certain cytochemical reactions reflect cellular function or maturation status. For example, the neutrophil alkaline phosphatase score can help distinguish chronic myeloid leukemia from leukemoid reaction, while nonspecific esterase can suggest monocytic differentiation.
1.2 Methodological Characteristics
(1) Dependence on morphological background
Cytochemical staining must be interpreted together with smear morphology. The cell type showing positive granules, the staining intensity, and the percentage of positive cells all need to be evaluated microscopically in combination with cell size, nuclear morphology, cytoplasmic volume, granules, and maturation stage.
(2) Mostly semi-quantitative results
Most hematologic cytochemical staining results are reported as negative, weakly positive, positive, strongly positive, or as a score. They are essentially semi-quantitative or categorical interpretations and should not be directly equated with precise enzymatic activity quantification.
(3) Strong influence of sample quality
Bone marrow smear thickness, cellular integrity, anticoagulants, fixation conditions, staining solution freshness, incubation temperature, and reaction time can all affect staining results. Cytochemical staining requires highly consistent sample pretreatment.
Table 1 Main Types of Hematologic Cytochemical Staining
Staining Type | Main Detection Target | Typical Positive Cells | Main Use |
Peroxidase staining (MPO/POX) | Myeloperoxidase | Granulocytic cells, some myeloid blasts | Preliminary differentiation of myeloid and lymphoid lineages |
Sudan Black B staining (SBB) | Lipids, phospholipids, and myeloid granule-related components | Granulocytic cells, some monocytic cells | Auxiliary assessment of myeloid differentiation |
Specific esterase staining | Chloroacetate esterase and related enzymes | Granulocytic cells | Identification of granulocytic differentiation |
Nonspecific esterase staining | α-Naphthyl esterases | Monocytes, macrophages | Identification of monocytic differentiation |
PAS staining | Glycogen, glycoproteins, polysaccharides | Abnormal erythroid cells, lymphoblasts, etc. | Evaluation of erythroleukemia, ALL, and some abnormal proliferations |
Neutrophil alkaline phosphatase staining | Neutrophil alkaline phosphatase | Mature neutrophils | Auxiliary differentiation between CML and leukemoid reaction |
Iron staining | Intracellular and extracellular iron | Bone marrow macrophages, sideroblasts | Evaluation of bone marrow iron stores and sideroblasts |
Acid phosphatase staining | Acid phosphatase | Some lymphocytes, monocytes, hairy cells, etc. | Auxiliary assessment of specific lymphoproliferative diseases |
2 Peroxidase Staining
2.1 Staining Principle
Peroxidase staining is mainly used to demonstrate myeloperoxidase activity. Myeloperoxidase is present in the azurophilic granules of granulocytic cells and some myeloid blasts. It can catalyze the oxidation of chromogenic substrates by hydrogen peroxide, forming yellow-brown, brown-black, or dark granular deposits.
The core significance of this reaction is to determine whether blasts show myeloid differentiation. In general, granulocytic cells are MPO-positive, monocytic cells may be weakly positive or negative, and lymphoid blasts are usually negative.
2.2 Application Scenarios
(1) Preliminary classification of acute leukemia
In the morphological diagnosis of acute leukemia, MPO positivity supports acute myeloid leukemia. MPO negativity suggests the need to consider acute lymphoblastic leukemia, undifferentiated acute leukemia, or some poorly differentiated AML. Results still need to be interpreted together with flow cytometric immunophenotyping and genetic testing.
(2) Assessment of myeloid differentiation
When some blasts show atypical morphology, MPO staining helps confirm whether myeloid granule enzyme activity is present. Positive granules are distributed in the cytoplasm and are often associated with the degree of cellular differentiation.
(3) Auxiliary evaluation of bone marrow after treatment
In post-treatment bone marrow, MPO staining can help identify regenerating granulocytic cells and residual abnormal cells, but it is not suitable as an independent method for minimal residual disease detection.
2.3 Interpretation Points
MPO interpretation should focus on the percentage of positive cells, granule intensity, and morphology of positive cells. Mature neutrophils are usually strongly positive. Weak positivity in blasts should be interpreted cautiously to avoid misinterpreting nonspecific deposits or background granules as true positivity.
Table 2 Interpretation of Peroxidase Staining Results
Cell Type | Common Reaction | Interpretation Significance | Notes |
Neutrophils | Strongly positive | Feature of mature granulocytic cells | Can serve as an internal control |
Myeloblasts | Negative to positive | Positivity supports myeloid differentiation | Poorly differentiated AML may be weakly positive or negative |
Monocytes | Negative to weakly positive | Unstable; should be combined with NSE | Not suitable alone for determining monocytic differentiation |
Lymphoblasts | Usually negative | Supports lymphoid direction | Requires immunophenotyping |
Eosinophils | May be positive | Granules are prominent | Should be identified with morphology |
3 Sudan Black B Staining
3.1 Staining Principle
Sudan Black B is a fat-soluble dye that stains intracellular lipids, phospholipids, and myeloid granule-related components. In hematologic cytochemistry, Sudan Black B is commonly used to demonstrate cytoplasmic granules in granulocytic cells, usually appearing as black or blue-black granules.
SBB has clinical uses similar to MPO, and both can be used to assess myeloid differentiation. SBB positivity usually supports granulocytic or some monocytic differentiation, while lymphoid cells are mostly negative.
3.2 Application Scenarios
(1) Auxiliary differentiation of acute myeloid leukemia
SBB positivity supports myeloid origin, especially when MPO results are weak or require supplementary assessment.
(2) Observation of granulocytic maturation stage
As granulocytic cells mature, SBB-positive granules usually become more prominent. Mature granulocytes are strongly positive, while early blasts may show weaker positivity.
(3) Complementary use with MPO
SBB detects lipids and granule-related components rather than MPO enzyme activity directly, so SBB and MPO results are not completely equivalent. In some cases, they confirm each other; in others, staining intensity may differ.
3.3 Interpretation Boundaries
SBB may show dark background staining, and lipids or nonspecific hydrophobic structures may interfere with interpretation. Results should be interpreted based on cell morphology, granule location, and control cell reactions rather than the overall color of the smear alone.
Table 3 Comparison Between MPO and SBB Staining
Comparison Dimension | MPO Staining | SBB Staining |
Detection target | Myeloperoxidase activity | Lipids, phospholipids, and myeloid granule-related components |
Typical positive cells | Granulocytic cells | Granulocytic cells, some monocytic cells |
Value in myeloid assessment | High | High; often complementary to MPO |
Positive appearance | Brown to dark cytoplasmic granules | Black or blue-black cytoplasmic granules |
Main limitation | Enzyme activity is affected by fixation and reaction conditions | Background and nonspecific staining need to be controlled |
4 Esterase Staining
4.1 Specific Esterase Staining
(1) Staining principle
Specific esterase staining is commonly represented by naphthol AS-D chloroacetate esterase staining and mainly demonstrates esterase activity in granulocytic cells. Positive reactions usually appear as red, purplish-red, or brown-red granular deposits localized in the cytoplasm.
(2) Application value
Specific esterase positivity supports granulocytic differentiation and can be used to identify granulocytic components in acute myeloid leukemia. Together with MPO and SBB, it forms an important cytochemical combination for assessing granulocytic differentiation.
(3) Interpretation notes
Mature granulocytes are often strongly positive, while myeloblasts may be weakly positive. If smears are overfixed or reaction conditions are inappropriate, enzyme activity may be reduced, causing false-negative results.
4.2 Nonspecific Esterase Staining
(1) Staining principle
Nonspecific esterase staining commonly uses α-naphthyl acetate or α-naphthyl butyrate as substrates and mainly demonstrates esterase activity associated with monocytes and macrophages. Positive reactions are often diffuse or granular cytoplasmic staining.
(2) Identification of monocytic lineage
Monocytes, immature monocytes, and some monocytoid leukemic cells often show NSE positivity. This staining is valuable in differentiating acute monocytic leukemia and acute myelomonocytic leukemia.
(3) Sodium fluoride inhibition test
Nonspecific esterase activity in monocytic cells is usually inhibited by sodium fluoride. If the NSE-positive reaction is markedly inhibited by NaF, monocytic differentiation is supported. If it is not inhibited, other cell origins or nonspecific reactions should be considered.
4.3 Combined Interpretation
In acute leukemia, combined use of specific esterase and nonspecific esterase helps distinguish granulocytic, monocytic, and mixed granulocytic-monocytic differentiation. Granulocytic cells are usually specific esterase-positive; monocytic cells are usually NSE-positive and NaF-inhibitable; acute myelomonocytic leukemia may show both positive cell populations.
Table 4 Application Differences of Esterase Staining
Staining Type | Common Substrate Direction | Main Positive Cells | Inhibition Feature | Main Use |
Specific esterase | Naphthol chloroacetate esters | Granulocytic cells | NaF inhibition is usually not the core interpretation criterion | Identification of granulocytic differentiation |
Nonspecific esterase | α-Naphthyl acetate, α-naphthyl butyrate | Monocytes, macrophages | Monocytic positivity is often inhibited by NaF | Identification of monocytic differentiation |
Dual esterase staining | Combination of two substrate types | Granulocytic and monocytic cells | Can distinguish two types of positive reactions | Auxiliary assessment of acute myelomonocytic leukemia |
5 PAS Staining
5.1 Staining Principle
PAS staining refers to periodic acid-Schiff staining. Periodic acid oxidizes vicinal diol structures in carbohydrates to generate aldehyde groups, which then react with Schiff reagent to form a purplish-red or magenta signal. In hematologic cells, PAS mainly demonstrates glycogen, glycoproteins, and some polysaccharide-related components.
5.2 Application Scenarios
(1) Acute lymphoblastic leukemia
Lymphoblasts may show PAS positivity, often with coarse granular or block-like positivity. This feature can serve as an auxiliary morphological indicator for ALL but cannot replace immunophenotyping.
(2) Erythroleukemia and abnormal erythroid proliferation
Abnormal erythroid cells may show PAS positivity, especially in cases of abnormal erythroblast proliferation. Normal erythroblasts are usually PAS-negative or weakly reactive, while abnormal positivity suggests dysplastic erythropoiesis.
(3) Megakaryocyte and platelet-related observation
Megakaryocytes and platelets may be PAS-positive, which can help identify the platelet system and some megakaryocytic abnormalities.
5.3 Interpretation Points
The PAS positivity pattern is more meaningful than positivity intensity alone. Diffuse, fine granular, coarse granular, or block-like positivity suggests different intracellular carbohydrate distribution patterns. Interpretation should be combined with cell lineage, morphological abnormalities, and other cytochemical results.
Table 5 Common PAS Staining Result Patterns
Cell Type | Common PAS Reaction | Interpretation Significance | Notes |
Lymphoblasts | Granular or block-like positivity may be seen | Supports auxiliary assessment of ALL | Requires immunophenotyping |
Normal erythroblasts | Mostly negative or weakly positive | Normal erythroid feature | Strong positivity suggests abnormal erythroid lineage |
Abnormal erythroid cells | May be clearly positive | Supports dysplastic erythropoiesis | Should be combined with bone marrow morphology and genetics |
Megakaryocytes | Often positive | Reflects abundant glycoproteins | Can help identify megakaryocytes |
Granulocytic cells | May be weakly positive or nonspecific | Limited diagnostic specificity | Not a core marker for granulocytic identification |
6 Neutrophil Alkaline Phosphatase Staining
6.1 Staining Principle
Neutrophil alkaline phosphatase staining is used to demonstrate alkaline phosphatase activity in mature neutrophils. Reaction products are usually localized in the cytoplasm of mature neutrophils, and results are generally scored based on staining intensity and the proportion of positive cells.
6.2 Clinical Applications
(1) Differentiation between CML and leukemoid reaction
The NAP score is usually decreased in chronic myeloid leukemia and often increased in leukemoid reaction. This indicator was once an important laboratory basis for differentiating the two.
(2) Evaluation of infection and inflammatory status
Severe infection, inflammatory stimulation, and stress states may increase neutrophil alkaline phosphatase activity, suggesting neutrophil functional activation.
(3) Auxiliary assessment of myeloproliferative diseases
NAP scoring can provide reference value for differentiating some myeloproliferative diseases, but modern diagnosis relies more on genetics, molecular markers, and comprehensive clinical assessment.
6.3 Interpretation Limitations
The NAP score is affected by infection, drugs, pregnancy, hormones, sample storage, and operating conditions. It cannot be used alone to diagnose CML or other myeloproliferative diseases and should be interpreted together with BCR-ABL1 testing, blood counts, bone marrow morphology, and clinical presentation.
Table 6 Common Interpretation of NAP Staining Results
Result Pattern | Common Background | Interpretation Direction | Notes |
Decreased NAP score | Common in CML | Supports chronic myeloid leukemia direction | Requires BCR-ABL1 confirmation |
Increased NAP score | Leukemoid reaction, infection, inflammation | Supports reactive granulocytosis | Should be combined with infection markers |
Normal NAP score | Seen in multiple conditions | Limited diagnostic specificity | Should not be used alone to exclude disease |
Strong positivity in mature neutrophils | Reactive activation | Functional activation | Strongly affected by clinical status |
7 Iron Staining
7.1 Staining Principle
Bone marrow iron staining commonly uses the Prussian blue reaction to demonstrate ferric iron. Iron reacts with acidic ferrocyanide to form blue deposits, allowing observation of extracellular storage iron in bone marrow and intracellular iron granules in erythroblasts.
7.2 Application Scenarios
(1) Evaluation of bone marrow storage iron
Blue granules in bone marrow macrophages reflect storage iron status. Iron deficiency anemia often shows reduced or absent bone marrow storage iron.
(2) Observation of sideroblasts
Erythroblasts containing blue iron granules in the cytoplasm are called sideroblasts. If iron granules are arranged around the nucleus in a ring, they are called ring sideroblasts, which are important morphological clues in some myelodysplastic syndromes and sideroblastic anemia.
(3) Differentiation of anemia
Iron staining helps distinguish iron deficiency anemia, anemia of chronic disease, sideroblastic anemia, and some MDS-related anemias.
7.3 Interpretation Points
Iron staining requires separate evaluation of extracellular and intracellular iron. Extracellular iron reflects storage iron, while intracellular iron reflects erythroid iron utilization. Iron contamination of smears, improper decolorization, or insufficient marrow particles can all affect interpretation.
Table 7 Interpretation Directions of Bone Marrow Iron Staining
Observation Target | Positive Appearance | Main Significance | Common Application |
Extracellular iron | Blue granules in macrophages or marrow particles | Storage iron level | Differentiation of iron deficiency anemia and anemia of chronic disease |
Sideroblasts | Blue iron granules in erythroblast cytoplasm | Erythroid iron utilization status | Anemia classification and erythroid maturation evaluation |
Ring sideroblasts | Iron granules arranged around the nucleus | Abnormal mitochondrial iron deposition | MDS, sideroblastic anemia |
Negative or very little iron | Lack of storage iron | Supports iron deficiency | Should be combined with serum ferritin and clinical indicators |
8 Acid Phosphatase and Other Special Stains
8.1 Acid Phosphatase Staining
Acid phosphatase staining can demonstrate acid phosphatase activity in some lymphocytes, monocytes, macrophages, and certain abnormal cells. It has auxiliary value in diseases such as hairy cell leukemia. Tartrate-resistant acid phosphatase (TRAP) reaction was once used as an auxiliary diagnostic method for hairy cell leukemia.
8.2 β-Glucuronidase Staining
β-Glucuronidase staining can reflect enzyme activity associated with parts of the monocyte-macrophage system and can be used as a supplementary indicator for monocytic differentiation, although its routine clinical use is less frequent than MPO, SBB, esterase, and PAS staining.
8.3 Enzyme Stains Other Than Alkaline Phosphatase
Some laboratories may also perform acid esterase, phosphatase, dehydrogenase, and other stains for specific research or auxiliary disease assessment. These methods require clearly defined detection purposes, positive controls, and interpretation criteria.
9 Combined Application of Hematologic Cytochemical Staining
9.1 Preliminary Differentiation of Acute Leukemia
In acute leukemia, MPO, SBB, specific esterase, nonspecific esterase, and PAS are commonly used to preliminarily distinguish myeloid, monocytic, and lymphoid differentiation. MPO or SBB positivity supports myeloid differentiation; NSE positivity with NaF inhibition supports monocytic differentiation; coarse granular or block-like PAS positivity may suggest lymphoblasts or abnormal erythroid features.
9.2 Assessment of AML Subtypes
In acute granulocytic leukemia, MPO, SBB, and specific esterase are often positive. In acute monocytic leukemia, nonspecific esterase positivity is more meaningful. In acute myelomonocytic leukemia, cytochemical features of both granulocytic and monocytic lineages may coexist.
9.3 Evaluation of Anemia and Erythroid Abnormalities
Iron staining and PAS staining can be used for anemia classification and evaluation of abnormal erythroid proliferation. Iron staining focuses on storage iron, sideroblasts, and ring sideroblasts; PAS staining may suggest dysplastic erythropoiesis and some erythroleukemia-related changes.
9.4 Auxiliary Assessment of Myeloproliferative Diseases
NAP staining can serve as an auxiliary method for evaluating neutrophil functional status and reactive granulocytosis. Chronic myeloid leukemia often shows a reduced NAP score, but modern diagnosis must be combined with molecular tests such as BCR-ABL1.
Table 8 Cytochemical Staining Combinations in Common Disease Scenarios
Disease or Scenario | Recommended Staining Combination | Typical Clues | Interpretation Focus |
Acute myeloid leukemia | MPO, SBB, specific esterase | Myeloid cells positive | Requires flow cytometric immunophenotyping |
Acute monocytic leukemia | NSE, NaF inhibition test, MPO | NSE-positive and inhibited by NaF | Distinguish monocytic from granulocytic differentiation |
Acute myelomonocytic leukemia | Specific esterase, NSE, MPO | Granulocytic and monocytic reactions coexist | Focus on different positive cell populations |
Acute lymphoblastic leukemia | PAS, MPO, SBB | PAS may be positive; MPO/SBB mostly negative | Cannot replace immunophenotyping |
Iron deficiency anemia | Iron staining | Reduced or absent storage iron | Combine with ferritin and red cell indices |
MDS with ring sideroblasts | Iron staining, PAS | Increased ring sideroblasts | Combine with morphology and genetics |
CML vs leukemoid reaction | NAP staining | Low in CML, high in leukemoid reaction | Requires BCR-ABL1 confirmation |
10 Quality Control and Common Problems
10.1 Smear Quality
Hematologic cytochemical staining requires smears of appropriate thickness, uniform cell distribution, and intact cell morphology. Excessively thick smears may cause uneven staining and high background; overly thin smears may contain too few positive cells, making scoring and classification difficult.
10.2 Fixation Conditions
Different cytochemical stains have different sensitivities to fixatives. Enzyme stains in particular require avoidance of overfixation, which can reduce enzyme activity. Fixation time, fixative type, and sample drying status should be strictly controlled according to the specific staining method.
10.3 Control Setup
Positive and negative controls should be included in each staining run. Mature neutrophils can serve as internal controls for MPO and SBB. Known positive samples can be used for quality control of esterase, PAS, NAP, and iron staining.
10.4 Result Interpretation
Cytochemical staining results should be interpreted together with cellular morphology, peripheral blood findings, bone marrow morphology, flow cytometric immunophenotyping, karyotyping, and molecular testing. A single positive or negative stain cannot independently establish a diagnosis of hematologic malignancy.
Table 9 Common Problems and Optimization Directions in Hematologic Cytochemical Staining
Problem | Possible Cause | Impact on Results | Optimization Direction |
Overall weak enzyme staining | Overfixation, reagent failure, insufficient reaction time | Risk of false negatives | Optimize fixation and include positive controls |
Deep background staining | Smear too thick, insufficient washing, stain precipitation | Difficult interpretation of positive granules | Improve smear quality and filter staining solution |
Unclear positive granules | Improper reaction time, unstable chromogenic substrate | Difficult grading | Control incubation time and temperature |
Large fluctuation in NAP score | Improper sample storage, insufficient cells counted | Poor comparability between groups | Standardize sampling and counting rules |
False-positive iron staining | Exogenous iron contamination, slide contamination | Overestimation of storage iron | Use clean instruments and include blanks |
Inconsistent PAS results | Unstable oxidation time or Schiff reagent condition | Bias in positivity intensity | Control periodic acid oxidation time and reagent freshness |
11 Reagent Selection Related to Hematologic Cytochemical Staining
Table 10 Common Basic Reagents and Materials for Hematologic Cytochemical Staining
Product Category | Product Name | CAS No. | Role in the System | Applicable Direction |
Peroxidase chromogenic substrate | 3,3'-Diaminobenzidine (DAB) | Peroxidase chromogenic substrate | MPO/POX staining, enzyme histochemical visualization | |
Lipid dye | Sudan Black B | Stains lipids, phospholipids, and myeloid granule-related components | SBB staining, auxiliary assessment of myeloid differentiation | |
Lipid dye | Sudan III | Demonstrates neutral lipids | Observation of lipid granules and fat components | |
Lipid dye | Sudan IV | Demonstrates neutral lipids | Lipid deposition and lipid droplet observation | |
PAS oxidant | Periodic acid | Oxidizes vicinal diols in carbohydrates to form aldehyde groups | Oxidation step before PAS staining | |
Glycogen digestion control | Amylase | Digests glycogen to verify the source of PAS positivity | PAS staining quality control and specificity validation | |
Iron staining reagent | Potassium ferrocyanide | Forms Prussian blue reaction with ferric iron | Bone marrow iron staining | |
Nonspecific esterase substrate | α-Naphthyl acetate | NSE reaction substrate | Monocyte- and macrophage-related esterase staining | |
Nonspecific esterase substrate | α-Naphthyl butyrate | NSE reaction substrate | Auxiliary assessment of monocytic differentiation | |
Specific esterase substrate | Naphthol AS-D chloroacetate | Specific esterase reaction substrate | Identification of granulocytic differentiation | |
Azo coupling salt | Fast Blue RR Salt | Couples with naphthol products for color development | Esterase and phosphatase staining | |
Azo coupling salt | Fast Garnet GBC Salt | Azo coupling chromogen | Esterase and phosphatase histochemistry | |
Azo coupling salt | Fast Red Violet LB Salt | Forms red deposits by coupling | Esterase and phosphatase staining | |
Esterase inhibitor | Sodium fluoride | Inhibits monocytic nonspecific esterase | NSE sodium fluoride inhibition test | |
Alkaline phosphatase substrate | Naphthol AS-BI phosphate | Alkaline phosphatase chromogenic substrate | NAP staining | |
TRAP inhibition/differentiation reagent | L-Tartaric acid | Used for tartrate-resistant acid phosphatase differentiation | TRAP staining, auxiliary assessment of hairy cell leukemia |
Table 11 Ready-to-Use Reagent Kits and Auxiliary Materials for Hematologic Cytochemical Staining
Product Category | Cat. No. | Product Name | Grade / Specification | Role in the System | Applicable Direction |
PAS chromogenic reagent | Schiff Reagent | BioReagent,Biological Stain,for microscopy | Reacts with aldehyde groups generated after periodic acid oxidation to produce a magenta signal | PAS staining, glycogen and glycoprotein demonstration; suitable for hematologic cytochemical PAS systems | |
Peroxidase staining | Peroxidase Staining Solution (Oxidase WG-KI Method) | BioReagent,Biological Stain,for microscopy | Demonstrates intracellular peroxidase-related reactions | MPO/POX staining, auxiliary assessment of myeloid differentiation in acute leukemia | |
Peroxidase staining | Peroxidase Staining Solution (Benzidine Method) | BioReagent,Biological Stain,for microscopy | Peroxidase catalyzes substrate oxidation to form chromogenic deposits | Granulocytic cell identification and auxiliary differentiation of myeloid blasts | |
Sudan Black B staining | Sudan Black B Staining Solution | BioReagent,for microscopy,Biological Stain | Demonstrates intracellular lipids, phospholipids, and myeloid granule-related components | SBB staining, auxiliary differentiation between AML and ALL | |
Sudan Black B staining | Sudan Black B Staining Solution | BioReagent,for microscopy,Biological Stain | Forms black or blue-black granular staining signals | Granulocytic differentiation, myeloid granule observation, hematologic cytochemical staining | |
PAS combined staining | AB-PAS staining kit | BioReagent, for microscopy, Biological Stain | Simultaneously demonstrates acidic mucosubstances and PAS-positive components | Observation of carbohydrate components in tissues/cells; extended PAS-related system | |
Glycogen PAS staining | Glycogen D-PAS Staining Solution (Amylase Digestion) | BioReagent, for microscopy, Biological Stain | Uses amylase digestion to verify whether PAS positivity originates from glycogen | Quality control for hematologic PAS staining and specificity validation of glycogen positivity | |
Glycogen PAS staining | Glycogen PAS staining kit | BioReagent, Biological Stain, for microscopy | Demonstrates glycogen, glycoproteins, and polysaccharide components | Observation of PAS positivity patterns in ALL, abnormal erythroid proliferation, erythroleukemia, etc. | |
Glycogen PAS staining | Glycogen PAS Staining Kit (Special For Cell) | BioReagent, Biological Stain, for microscopy | Optimized PAS staining system for cultured cell samples | Observation of glycogen and glycoprotein components in cultured hematologic cells or cell lines | |
Prussian blue iron staining | Prussian blue | Biological Stain | Chromogenic material related to iron staining | Iron staining-related material; suitable for method expansion in iron deposition observation | |
Prussian blue iron staining | Prussian blue soluble | Biological Stain | Chromogenic material related to iron staining | Prussian blue-related staining systems and iron deposition observation | |
Prussian blue iron staining | Prussian Blue Staining Solution (DAB Enhancement Method) | BioReagent,for microscopy,Biological Stain | Enhances Prussian blue iron staining signals | Bone marrow iron staining, observation of weakly positive iron granules, enhanced iron deposition visualization | |
Prussian blue iron staining | Prussian Blue Staining Kit (Neutral Red) | BioReagent, Biological Stain, for microscopy | Demonstrates ferric iron and uses neutral red counterstaining for localization | Observation of bone marrow storage iron, sideroblasts, and tissue iron deposition | |
Prussian blue iron staining | Prussian Blue Staining Kit (Eosin) | BioReagent, Biological Stain, for microscopy | Combines Prussian blue iron reaction with eosin counterstaining | Bone marrow or tissue iron staining; auxiliary cellular morphology localization | |
Prussian blue iron staining | Prussian Blue Staining Kit (Nuclear Fast Red) | BioReagent, for microscopy, Biological Stain | Combines Prussian blue iron reaction with nuclear fast red counterstaining | Bone marrow iron staining, sideroblast identification, tissue iron deposition localization | |
Basic morphology staining | Wright-Giemsa Staining Kit | BioReagent, Biological Stain, for microscopy | Provides basic morphological background for blood and bone marrow cells | Combined interpretation with MPO, SBB, PAS, iron staining, and other cytochemical results | |
Mounting material | Fischor Mounting Medium | BioReagent,for microscopy,Suitable for Immunofluorescence(IF),Suitable for Immunohistochemistry(IHC) | Mounting after staining to maintain microscopic observation condition | Hematologic cytochemical staining, histological staining, and image acquisition | |
Mounting material | mounting medium | Unscented | Routine mounting | Microscopic observation after smear or tissue section staining | |
Glycerol mounting | Routine Glycerol Mounting Medium | BioReagent,for microscopy,Suitable for Immunofluorescence(IF),for fluorescence analysis | Aqueous or semi-aqueous mounting to preserve stained samples | Cell smears, fluorescence combined staining, or temporary observation | |
Glycerol-PBS mounting | Glycerol PBS Mounting Medium | BioReagent,for microscopy,Suitable for Immunofluorescence(IF),for fluorescence analysis | Buffered glycerol mounting system | Smear observation after staining, fluorescent or enzyme-staining combined samples | |
Antifade mounting | Enhanced Antifade Mounting Medium | BioReagent, for fluorescence analysis, Suitable for Immunofluorescence(IF) | Reduces fluorescence signal decay | Cytochemical staining combined with immunofluorescence or fluorescent labeling experiments | |
Antifade mounting | Antifluorescent quencher |
| Protects fluorescence signal and reduces quenching | Fluorescent cytochemical staining and immunofluorescence combined observation | |
Antifade mounting | Polyvinyl Alcohol Anti-Fluorescence Quenching Mounting Medium | Suitable for Immunofluorescence(IF),BioReagent,for microscopy,for fluorescence analysis | Improves storage stability of fluorescent samples | Fluorescent staining samples and immunofluorescence-combined cytochemical experiments | |
Glycerol mounting | Polyvinyl Alcohol Glycerol Mounting Medium | BioReagent,for microscopy,Suitable for Immunofluorescence(IF),Suitable for Immunohistochemistry(IHC) | Provides a relatively stable mounting environment | Blood smears, tissue sections, and immunostained samples | |
Glycerol mounting | Gum Arabic Glycerol Mounting Medium | BioReagent,for microscopy,Suitable for microbiology,Suitable for Immunofluorescence(IF),Suitable for Immunohistochemistry(IHC) | Traditional glycerol-based mounting system | Mounting and long-term observation of microscopic staining samples |
The core value of hematologic cytochemical staining lies in combining cellular morphology with demonstration of functional components, providing directional evidence for the preliminary differentiation of hematologic diseases. In practice, smear quality, fixation conditions, positive controls, and interpretation standards should be kept consistent, and the results should be incorporated into an integrated diagnostic framework including morphology, immunophenotype, genetics, and molecular testing.
